Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice. 2003

Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
Department of Dermatology, Philipp University, Marburg, Germany. freyschm@mailer.uni-marburg.de

Alopecia areata is suspected to be a T cell-mediated autoimmune disease of the hair follicle, where Fas is expressed on hair follicles and Fas ligand on perifollicular infiltrates. To elucidate whether the Fas/Fas ligand pathway is of pathogenetic significance in alopecia areata, we investigated whether alopecia areata can be induced in Fas-deficient and Fas ligand-deficient mice and whether alopecia areata develops in Fas-deficient and Fas ligand-deficient skin. Therefore, we induced alopecia areata by grafting alopecia areata-affected C3H/HeJ mouse skin on to C3H/HeJ mice (control), on to Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice or Fas-deficient C3.MRL-Tnfrsf6(lpr) mice. All control mice developed alopecia areata, whereas no Fas-deficient mice showed hair loss and two of seven Fas ligand-deficient mice developed only transitory, limited alopecia areata. Moreover, skin from C3H/HeJ mice (control), C3H/HeJ-Tnfsf6(gld) mice, and C3.MRL-Tnfrsf6(lpr) mice was grafted on to C3H/HeJ mice with extensive alopecia areata. Skin grafts from control mice developed hair loss, whereas Fas-deficient and Fas ligand-deficient skin grafts were spared from alopecia areata. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling and immunofluorescence studies revealed an increased number of apoptotic cells and expression of Fas on hair follicles as well as expression of Fas ligand on cells of the perifollicular infiltrate in C3H/HeJ mice with alopecia areata, whereas in Fas-deficient and Fas ligand-deficient mice apoptotic cells were virtually absent in hair follicles. The results suggest that the Fas/Fas ligand pathway plays an important pathogenetic role in alopecia areata.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D000506 Alopecia Areata Loss of scalp and body hair involving microscopically inflammatory patchy areas. Alopecia Circumscripta
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D016038 Skin Transplantation The grafting of skin in humans or animals from one site to another to replace a lost portion of the body surface skin. Dermatoplasty,Grafting, Skin,Transplantation, Skin,Dermatoplasties,Graftings, Skin,Skin Grafting,Skin Graftings,Skin Transplantations,Transplantations, Skin

Related Publications

Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
April 1995, Journal of autoimmunity,
Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
June 2021, Journal of dermatological science,
Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
December 2014, Experimental and molecular pathology,
Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
August 1998, Cellular immunology,
Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
November 1998, The Journal of investigative dermatology,
Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
January 2001, In vivo (Athens, Greece),
Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
October 2013, Comparative medicine,
Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
October 2001, FEBS letters,
Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
February 2022, Experimental dermatology,
Pia Freyschmidt-Paul, and Kevin J McElwee, and Vladimir Botchkarev, and Sabine Kissling, and Elke Wenzel, and John P Sundberg, and Rudolf Happle, and Rolf Hoffmann
July 2000, Transplantation,
Copied contents to your clipboard!